Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / BRSCW Application: Lokshin - Univ of Pitts (2008)

BRSCW Application: Lokshin - Univ of Pitts (2008)

288
TgII, SCC, HSP 70, IGFBP-1,2, GH, sICAM-1, MMP-9, MPO, tPAI-1, CA72-4, CA15-3, EGFR, Osteopontin (OPN), Endostatin (RNDO), Thrombospondin (THBS), Angiostatin (ANGIO), Apolipoproteins (Apo) A1, A2, B, E), Resistin, and PAI-1
Case/control
Proteomics
Breast and Gynecologic Cancers Research

One KLK,(KLK6) ranked 6th among all tested biomarkers(approx.50)

1.   Validation of ovarian cancer biomarkers (pre- and post-menopausal women) 2.   Validation of breast cancer biomarkers
Luminex

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


News

The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 06/26/2014


Please click here to register for the 9th EDRN Scientific Workshop from September 8-10, 2014, in Bethesda, Maryland. The meeting registration page also has agendas and hotel reservation information.
Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html